These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9178203)

  • 41. [Asthma and sleep in children].
    Leupold W
    Pneumologie; 1997 Apr; 51 Suppl 2():440-3. PubMed ID: 9244892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fritillaria cirrhosa, Anemarrhena asphodeloides, Lee-Mo-Tang and cyclosporine a inhibit ovalbumin-induced eosinophil accumulation and Th2-mediated bronchial hyperresponsiveness in a murine model of asthma.
    Yeum HS; Lee YC; Kim SH; Roh SS; Lee JC; Seo YB
    Basic Clin Pharmacol Toxicol; 2007 Mar; 100(3):205-13. PubMed ID: 17309526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is phosphodiesterase inhibition a relevant bronchospasmolytic principle?
    Kilian U; Beume R; Eltze M; Schudt C
    Agents Actions Suppl; 1989; 28():331-48. PubMed ID: 2683636
    [No Abstract]   [Full Text] [Related]  

  • 44. [The efficacy and unsafeness of using antiasthmatic drug agents].
    Tsoĭ AN
    Ter Arkh; 1998; 70(3):81-4. PubMed ID: 9575597
    [No Abstract]   [Full Text] [Related]  

  • 45. [The efficacy of the magnesium sulfate aerosol treatment of bronchial asthma patients].
    Emel'ianov AV; Goncharova VA; Sinitsina TM
    Ter Arkh; 1997; 69(3):35-9. PubMed ID: 9229826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluticasone propionate and pentamidine isethionate reduce airway hyperreactivity, pulmonary eosinophilia and pulmonary dendritic cell response in a guinea pig model of asthma.
    Lawrence TE; Millecchia LL; Fedan JS
    J Pharmacol Exp Ther; 1998 Jan; 284(1):222-7. PubMed ID: 9435182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Bronchial reactivity as factor of effectiveness of new antiasthmatic drugs].
    Pol'ner SA; Chervinskaia TA
    Ter Arkh; 2000; 72(3):20-3. PubMed ID: 10776647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs.
    Aoki M; Yamamoto S; Kobayashi M; Ohga K; Kanoh H; Miyata K; Honda K; Yamada T
    J Pharmacol Exp Ther; 2001 Apr; 297(1):165-73. PubMed ID: 11259541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [On the studies and treatments of asthma, and their future].
    Ito K
    Arerugi; 1996 Jun; 45(6):533-41. PubMed ID: 8776947
    [No Abstract]   [Full Text] [Related]  

  • 50. UR-60427, a novel H4 receptor-inverse agonist that shows good efficacy in a rat asthma model.
    Alfón J; Ardanaz N; Gil-Torregrosa B; Fernández A; Balsa D; Carceller E; Gómez L; Merlos M; Cortijo J; Morcillo E; Bartrolí X
    Inflamm Res; 2010 Mar; 59 Suppl 2():S199-200. PubMed ID: 20020315
    [No Abstract]   [Full Text] [Related]  

  • 51. Therapeutic problems in the management of bronchial asthma.
    Segal MS; MacDonnell KF
    Compr Ther; 1980 Apr; 6(4):43-50. PubMed ID: 6104555
    [No Abstract]   [Full Text] [Related]  

  • 52. Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents.
    Wójcik-Pszczoła K; Jankowska A; Ślusarczyk M; Jakieła B; Plutecka H; Pociecha K; Świerczek A; Popiół J; Koczurkiewicz-Adamczyk P; Wyska E; Pękala E; Gosens R; Chłoń-Rzepa G
    Bioorg Chem; 2021 Dec; 117():105409. PubMed ID: 34749117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [From physiopathology to new developments in pharmacotherapy of bronchial asthma--a look into the future].
    Gillissen A; Schäfer H; Tasci S; Ewig S
    Pneumologie; 2000 Aug; 54(8):345-54. PubMed ID: 11008477
    [No Abstract]   [Full Text] [Related]  

  • 54. [Research on the mechanism of asthma and the development of new drugs].
    Chen JQ; Bian RL
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 32(4):269-73. PubMed ID: 12970924
    [No Abstract]   [Full Text] [Related]  

  • 55. Bronchial asthma: advice for patients traveling to high altitude.
    Cogo A; Fiorenzano G
    High Alt Med Biol; 2009; 10(2):117-21. PubMed ID: 19519226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bronchial hyperresponsiveness: what causes twitchy airways?
    Page C
    J Pharm Pharmacol; 1997 May; 49 Suppl 3():9-11. PubMed ID: 9178200
    [No Abstract]   [Full Text] [Related]  

  • 57. Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses.
    Hall IP
    Br J Clin Pharmacol; 1993 Jan; 35(1):1-7. PubMed ID: 8383516
    [No Abstract]   [Full Text] [Related]  

  • 58. [The role of hypoxia in the development of bronchial asthma].
    Ialkut SI
    Ter Arkh; 1995; 67(8):71-4. PubMed ID: 7482346
    [No Abstract]   [Full Text] [Related]  

  • 59. Theophylline and phosphodiesterase inhibitors.
    Aubier M; Barnes PJ
    Eur Respir J; 1995 Mar; 8(3):347-8. PubMed ID: 7789475
    [No Abstract]   [Full Text] [Related]  

  • 60. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
    Torphy TJ; Undem BJ
    Thorax; 1991 Jul; 46(7):512-23. PubMed ID: 1877039
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.